Formerly | Indegene Lifesystems Private Limited (1998–2016) Indegene Private Limited (2016–2022) |
---|---|
Company type | Public |
Industry | |
Founded | 1998; 26 years ago (1998) |
Founders | Rajesh Nair Manish Gupta Sanjay Parikh Anand Kiran Gaurav Kapoor |
Headquarters | , India |
Area served | Worldwide |
Key people | Manish Gupta (CEO)[1] |
Revenue | ₹2,589 crore (US$310 million) (FY24)[2] |
₹584 crore (US$70 million) (FY24)[2] | |
₹336 crore (US$40 million) (FY24)[2] | |
Owners |
|
Number of employees | 5,081 (March 2024)[2] |
Website | www |
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises.[4][5][6] Based in Bangalore, the company specializes in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics.[7][8]
Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran.[9] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States.[10] In 2008, Medsn officially became known as Indegene Pharmaceutical Solutions in the United States. In 2006, Indegene acquired MedCases, a continuing medical education company based in the United States.[6][11]
In 2009, Indegene signed a master service agreement with six pharmaceutical companies.[5][12] The following year, Indegene acquired Canada-based Aptilon, a multichannel marketing firm, for $4 million.[13] The company subsequently acquired Atlanta-based Total Therapeutic Management in 2014.[14]
In September 2019, Indegene acquired London-based consulting company, DT Associates, for $10 million.[15]
In February 2021, the Carlyle Group and Brighton Park Capital invested $200 million in Indegene.[16] In August 2021, Indegene acquired Medical Marketing Economics (MME), an American market access and pricing strategy company, for $10 million.[17]
Indegene went public in May 2024 with an initial public offering, raising ₹1,842 crore (US$220 million). It listed on the BSE and the NSE.[18]
Indegene has offices in India, the United States, the European Union, and Asia-Pacific.[19][11]
In 2011 and 2012, The Economic Times named Indegene one of the best companies to work for in the Professional Services industry.[20]